| 06/29 | REGULUS THERAPEUTICS INC. : REVERSE SPLIT: 1 of 10 | FA |
| 06/28 | Wall Street Set to Open Higher | MT |
| 06/28 | Top Premarket Decliners | MT |
| 06/21 | Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for .. | PR |
| 06/21 | Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for .. | CI |
| 06/21 | Regulus Therapeutics Gets FDA Orphan Designation for RGLS8429 | DJ |
| 06/13 | Regulus Reports First Individual Dosed in Early-Stage Single-Ascending Dose Trial of RG.. | MT |
| 06/13 | Regulus Therapeutics Announces First Subject Dosed in Phase 1 Single-Ascending Dose (SA.. | PR |
| 06/13 | Regulus Therapeutics Inc. Announces First Subject Dosed in Phase 1 Single-Ascending Dos.. | CI |
| 06/02 | Regulus Appoints Amin Kamel, Ph.D., as Vice President, DMPK | PR |
| 05/17 | Regulus Therapeutics to Present at the H.C. Wainwright Global Investment Conference | PR |
| 05/12 | TRANSCRIPT : Regulus Therapeutics Inc., Q1 2022 Earnings Call, May 12, 2022 | CI |
| 05/12 | REGULUS : Q1 Earnings Snapshot | AQ |
| 05/12 | Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31.. | CI |
| 05/12 | Regulus Therapeutics Reports First Quarter 2022 Financial Results and Recent Updates | PR |
| 05/11 | SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close | MT |
| 05/11 | SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance | MT |
| 05/11 | SECTOR UPDATE : Health Care | MT |
| 05/11 | Regulus Therapeutics' Shares Surge After FDA Accepts Investigational New Drug Applicati.. | MT |
| 05/11 | Regulus Therapeutics' Shares Climb After US FDA Accepts Investigational New Drug Applic.. | MT |
| 05/11 | Regulus Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Applica.. | PR |
| 05/11 | Regulus Therapeutics Inc. Announces FDA Acceptance of Investigational New Drug Applicat.. | CI |
| 05/05 | Regulus Therapeutics Announces Timing for First Quarter 2022 Financial Results Webcast .. | PR |
| 03/24 | Regulus Therapeutics Initiates Studies for Potential Treatment of Lou Gehrig's Disease;.. | MT |
| 03/24 | Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral.. | PR |
| 03/24 | Regulus Therapeutics Announces Initiation of Preclinical Studies in Amyotrophic Lateral.. | CI |
| 03/10 | TRANSCRIPT : Regulus Therapeutics Inc., Q4 2021 Earnings Call, Mar 10, 2022 | CI |
| 03/10 | REGULUS THERAPEUTICS : Reports Fourth Quarter and Year-End 2021 Financial Results and Rece.. | PU |
| 03/10 | REGULUS : Q4 Earnings Snapshot | AQ |
| 03/10 | Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Rec.. | PR |
| 03/10 | Regulus Therapeutics Inc. Reports Earnings Results for the Fourth Quarter and Full Year.. | CI |
| 03/03 | Regulus Therapeutics Announces Timing for Fourth Quarter and Year-End 2021 Financial Re.. | PR |
| 02/24 | Regulus Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of La.. | PR |
| 02/24 | Regulus Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of La.. | CI |
| 02/10 | Regulus Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Confer.. | PR |
| 01/21 | Health Care Stocks Decline Pre-Bell Friday | MT |
| 01/21 | Wedbush Adjusts Regulus Therapeutics' Price Target to $0.42 From $1 Following Private E.. | MT |
| 01/20 | Regulus Therapeutics Completes US FDA Meeting for Planned Kidney Disease Trial; Stock U.. | MT |
| 01/20 | Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RG.. | PR |
| 01/20 | Regulus Therapeutics Inc. Announces Successful Completion of Pre-Ind Meeting with FDA f.. | CI |
| 01/05 | Regulus Therapeutics Inc. Enters into Eleventh Amendment to its Loan and Security Agree.. | CI |
| 01/04 | Regulus Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference | PR |
| 2021 | Regulus Appoints Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceuti.. | PR |
| 2021 | Regulus Therapeutics Announces Presentation at the First Annual Rare & Genetic Kidney D.. | PR |
| 2021 | Regulus Therapeutics Raises $34.6 Million in Common Stock Private Placement | MT |
| 2021 | REGULUS THERAPEUTICS : SECURITIES PURCHASE AGREEMENT - Form 8-K | PU |
| 2021 | Regulus Therapeutics Announces Closing of $34.6 Million Private Placement of Equity | PR |
| 2021 | REGULUS THERAPEUTICS : Announces Private Placement of Equity - Form 8-K | PU |
| 2021 | Regulus Therapeutics Launches $35 Million Private Placement | MT |
| 2021 | Regulus Therapeutics Announces Private Placement of Equity | PR |
| 2021 | Regulus Therapeutics Reports Third Quarter 2021 Financial Results and Recent Updates - .. | PU |
| 2021 | TRANSCRIPT : Regulus Therapeutics Inc., Q3 2021 Earnings Call, Nov 10, 2021 | CI |
| 2021 | REGULUS : Q3 Earnings Snapshot | AQ |
| 2021 | Regulus Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Month.. | CI |
| 2021 | Regulus Therapeutics Announces Timing for Third Quarter 2021 Financial Results Webcast .. | PR |
| 2021 | AFTER HOURS WATCH LIST SCORECARD : Vst, stim, rgls | MT |
| 2021 | Health Care Stocks Edging Higher Ahead of Wednesday Close | MT |
| 2021 | Health Care Stocks Finding Increased Support This Afternoon | MT |
| 2021 | Wall Street Wavers Pre-Bell as US Consumer Prices Rise More Than Expected, Fed Minutes .. | MT |
| 2021 | Top Premarket Decliners | MT |
| 2021 | MT NEWSWIRES AFTER HOURS WATCH LIST : Vst, stim, rgls | MT |
| 2021 | TRANSCRIPT : Regulus Therapeutics Inc. - Special Call | CI |
| 2021 | REGULUS THERAPEUTICS : Shifting Development Focus to Next-Generation Kidney Drug; Stock Pl.. | MT |
| 2021 | REGULUS THERAPEUTICS : Announces Strategic Prioritization of RGLS8429, its Next-Generation.. | PR |
| 2021 | Regulus Therapeutics Announces Strategic Prioritization of RGLS8429, its Next-Generatio.. | CI |
| 2021 | REGULUS THERAPEUTICS : to Present at the H.C. Wainwright 23rd Annual Global Investment Con.. | PR |
| 2021 | REGULUS THERAPEUTICS : Cantor Fitzgerald Reinstates Regulus Therapeutics at Overweight wit.. | MT |
| 2021 | TRANSCRIPT : Regulus Therapeutics Inc., Q2 2021 Earnings Call, Aug 10, 2021 | CI |
| 2021 | REGULUS : Q2 Earnings Snapshot | AQ |
| 2021 | REGULUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Updates (F.. | PU |
| 2021 | REGULUS THERAPEUTICS : Narrows Q2 Loss from Year Ago, Sees Enough Funds Till Q4 Next Year | MT |
| 2021 | Regulus Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30.. | CI |
| 2021 | REGULUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Recent Updates | PR |
| 2021 | REGULUS THERAPEUTICS : Announces Timing for Second Quarter 2021 Financial Results Webcast .. | PR |
| 2021 | REGULUS THERAPEUTICS : Presents Additional Data from its Autosomal Dominant Polycystic Kid.. | PR |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
